Pralidoxime
๐ Pralidoxime is used as an adjunct to atropine in the treatment of poisoning by organophosphorus insecticides or nerve agents (e.g. sarin).
It reactivates acetylcholinesterase, reversing the life-threatening cholinergic crisis.
๐ About
Always check the BNF link here for the latest prescribing information.
Pralidoxime is an oxime antidote used in acute cholinesterase inhibitor poisoning.
โ๏ธ Mode of Action
- ๐ Reactivates acetylcholinesterase by cleaving the phosphate-enzyme bond formed by organophosphates.
- โก Restores normal breakdown of acetylcholine at neuromuscular junctions.
- ๐ก๏ธ Best given early (before โagingโ of the phosphorylated enzyme, when reactivation becomes irreversible).
๐ Indications / Dose
- Organophosphate or nerve agent poisoning (e.g. sarin, parathion):
30 mg/kg IV infusion over 20 minutes, then 8 mg/kg/hour continuous infusion.
โ ๏ธ Maximum 12 g in 24 hours.
- ๐ Always given in conjunction with atropine to control muscarinic effects (bronchorrhoea, bradycardia, bronchospasm).
๐ Interactions
- ๐ See BNF for details.
- โ ๏ธ May interfere with anticholinesterases used in myasthenia gravis (e.g. neostigmine, pyridostigmine).
โ ๏ธ Cautions
- ๐คฒ Myasthenia gravis โ risk of precipitating weakness.
- ๐ง Use cautiously in elderly patients (risk of cardiac complications).
โ Contraindications
- ๐ซ See BNF for full list.
- Relative: hypersensitivity to pralidoxime or oximes.
๐ฌ Side Effects
- โฌ๏ธ Hypertension, tachycardia or reflex bradycardia.
- ๐คข Nausea, vomiting, abdominal cramps.
- ๐ค Headache, dizziness, blurred vision, diplopia.
- ๐ฎ Laryngospasm, muscle rigidity, hyperventilation (rare, high dose).
๐ References
- BNF: Pralidoxime
- WHO guidelines for organophosphate poisoning.
- UK Health Security Agency (UKHSA): Management of chemical incidents.
๐ Revisions